Baird DT - Search Results

1

A single dose of mifepristone (200 mg) in the immediate preovulatory phase offers contraceptive potential without cycle disruption.

Brown A, Williams A, Cameron S, Morrow S, Baird DT. Brown A, et al. Among authors: baird dt. Contraception. 2003 Sep;68(3):203-9. doi: 10.1016/s0010-7824(03)00146-x. Contraception. 2003. PMID: 14561541

2

Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: a double-blind randomized control trial of 2 and 5 mg per day for 120 days.

Brown A, Cheng L, Lin S, Baird DT. Brown A, et al. Among authors: baird dt. J Clin Endocrinol Metab. 2002 Jan;87(1):63-70. doi: 10.1210/jcem.87.1.8140. J Clin Endocrinol Metab. 2002. PMID: 11788624 Clinical Trial.

3

Mifepristone: a novel estrogen-free daily contraceptive pill.

Baird DT, Brown A, Cheng L, Critchley HO, Lin S, Narvekar N, Williams AR. Baird DT, et al. Steroids. 2003 Nov;68(10-13):1099-105. doi: 10.1016/j.steroids.2003.07.002. Steroids. 2003. PMID: 14668004 Review.

4

Low-dose mifepristone inhibits endometrial proliferation and up-regulates androgen receptor.

Narvekar N, Cameron S, Critchley HO, Lin S, Cheng L, Baird DT. Narvekar N, et al. Among authors: baird dt. J Clin Endocrinol Metab. 2004 May;89(5):2491-7. doi: 10.1210/jc.2003-031945. J Clin Endocrinol Metab. 2004. PMID: 15126582 Clinical Trial.

5

Changes in vaginal morphology, steroid receptor and natural antimicrobial content following treatment with low-dose mifepristone.

Narvekar N, Lakha F, Critchley HO, Glasier AF, Williams AR, Leminen R, Heikinheimo O, Kelly RW, Baird DT. Narvekar N, et al. Among authors: baird dt. Contraception. 2007 Apr;75(4):271-80. doi: 10.1016/j.contraception.2006.11.013. Epub 2007 Jan 22. Contraception. 2007. PMID: 17362705 Clinical Trial.

6

Effects of onapristone on postmenopausal endometrium.

Cameron ST, Glasier AF, Narvekar N, Gebbie A, Critchley HO, Baird DT. Cameron ST, et al. Among authors: baird dt. Steroids. 2003 Nov;68(10-13):1053-9. doi: 10.1016/j.steroids.2003.07.004. Steroids. 2003. PMID: 14667998

7

Comparison of a transdermal continuous combined and an interrupted progestogen HRT.

Cameron ST, Glasier AF, Gebbie A, Dewart H, Baird DT. Cameron ST, et al. Among authors: baird dt. Maturitas. 2006 Jan 10;53(1):19-26. doi: 10.1016/j.maturitas.2005.01.013. Maturitas. 2006. PMID: 16325020 Clinical Trial.

8

Toward developing a once-a-month pill: a double-blind, randomized, controlled trial of the effect of three single doses of mifepristone given at midcycle on the pattern of menstrual bleeding.

Narvekar N, Glasier A, Dada K, Van der Spuy Z, Ho PC, Cheng L, Baird DT. Narvekar N, et al. Among authors: baird dt. Fertil Steril. 2006 Oct;86(4):819-24. doi: 10.1016/j.fertnstert.2006.02.115. Fertil Steril. 2006. PMID: 17027354 Free article. Clinical Trial.

9

Mifepristone-induced vaginal bleeding is associated with increased immunostaining for cyclooxygenase-2 and decrease in prostaglandin dehydrogenase in luteal phase endometrium.

Hapangama DK, Critchley HO, Henderson TA, Baird DT. Hapangama DK, et al. Among authors: baird dt. J Clin Endocrinol Metab. 2002 Nov;87(11):5229-34. doi: 10.1210/jc.2002-020429. J Clin Endocrinol Metab. 2002. PMID: 12414896

10

Antiprogestins as a model for progesterone withdrawal.

Critchley HO, Kelly RW, Brenner RM, Baird DT. Critchley HO, et al. Among authors: baird dt. Steroids. 2003 Nov;68(10-13):1061-8. doi: 10.1016/j.steroids.2003.07.001. Steroids. 2003. PMID: 14667999 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

428 results

Search Page

Filters